Market Newsdesk

ATLANTA, Sept. 15, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:

Pentair plc (PNR)

The shareholder class action lawsuit filed against Pentair plc (“Pentair”) (NYSE: PNR) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts between March 11, 2025 and July 14, 2026 regarding significant destocking of inventory in Pentair’s Pool channel and its effect on sales and operating income. If you purchased Pentair shares during this time period and suffered a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/pentair/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is October 2, 2026. 

Datavault AI Inc. (DVLT)

The shareholder class action lawsuit filed against Datavault AI Inc. (“Datavault AI”) (NASDAQ: DVLT) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts between September 4, 2024 and October 30, 2025 regarding the economic value of Datavault AI’s partnerships and the volume of trading activity on the Datavault Platform. If you purchased Datavault AI shares during this time period and suffered a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/datavault-ai/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is October 5, 2026. 

ARS Pharmaceuticals, Inc. (SPRY)

The shareholder class action lawsuit filed against ARS Pharmaceuticals, Inc. (“ARS”) (NASDAQ: SPRY) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts between March 9, 2026 and June 24, 2026 regarding ARS’s expected timeline for expanded insurance coverage for its epinephrine nasal spray, neffy, with CVS Caremark. If you purchased ARS shares during this time period and suffered a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/ars-pharmaceuticals/ to learn more.    

The deadline to ask the court to be appointed lead plaintiff in the case is October 5, 2026. 

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, https://holzerlaw.com/, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected]

TYLER, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) — ENvue Medical, Inc. (Nasdaq: FEED) (“ENvue” or the “Company”), a medical technology company focused on innovative solutions for enteral feeding and therapeutic ultrasound, today announced that it has received a decision from the Nasdaq Hearings Panel (the “Panel”) denying the Company’s request for continued listing on The Nasdaq Capital Market. As a result, trading of the Company’s common stock will be suspended and will begin trading on the OTC Markets under the same stock symbol, ‘FEED’, on September 16, 2026.

The Panel’s decision does not affect ENvue’s business operations, products, customers, or ongoing commercial activities. The Company continues to operate its business forward and remains focused on advancing the commercialization of the ENvue Navigation System and its broader medical technology portfolio, including PainShield® and UroShield®, while pursuing opportunities to expand adoption and commercialization of its technologies, supporting its customers and executing its commercial and operational strategy.

The Company is evaluating all available procedures and alternatives under the Nasdaq Listing Rules, including a further appeal.

“We are disappointed with the Panel’s decision and are evaluating all available paths forward,” said Doron Besser, M.D., Chief Executive Officer of ENvue Medical. “At the same time, our business continues. Our team remains focused on our customers, our products and the execution of our strategy. We will continue working to strengthen the Company and build long-term value for our shareholders.”

The Company intends to provide additional information regarding the Nasdaq process and the trading status of its common stock as appropriate.

About ENvue Medical, Inc.

ENvue Medical, Inc. (NASDAQ: FEED) is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings. Headquartered in Tyler, Texas, with research and development in Tel-Aviv and Nesher, Israel, the Company focuses on two distinct technology platforms:

• ENvue™ Navigation Platform, developed and operated by ENvue Medical Inc., with offices in Arlington Heights, Illinois, and Tel-Aviv, Israel, is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. FDA 510(k) cleared for adult use, ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Future platform expansion may include pediatric and vascular access applications.
• ENvue Medical aims to advance standards in non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation across a range of healthcare environments.
• Acoustic-based therapeutic technologies, including PainShield® and UroShield®, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms.

Forward-Looking Statements

This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential,” or similar words. These forward-looking statements include, but are not limited to: statements regarding continued growth in feeding tube sales, expected utilization of the ENvue™ Navigation Platform across the Company’s installed hospital base, anticipated recurring consumable demand associated with the Company’s commercial model, the potential for expanded adoption within existing hospital customers and health systems, and future expectations for the ENvue business. For example, the Company is using forward-looking statements when it discusses the expected trading of its common stock on the OTC Markets on September 16, 2026, its long-term business plans and that it continues to work to strengthen the Company and build long-term value for its shareholders. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified; consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation: (i) market acceptance of the Company’s existing and new products; (ii) clinical performance and operational outcomes; (iii) delays or complications in product implementation; (iv) intense competition in the medical device industry; (v) product liability or performance issues; (vi) limitations in manufacturing or supply chain capabilities; (vii) reimbursement limitations; (viii) intellectual property protection; (ix) healthcare regulatory changes in the U.S. and abroad; and (x) the need for additional capital. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (“SEC”), including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Investors and security holders are urged to read these documents free of charge at www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events, or otherwise, except as required by law.

Investor Contact:

KCSA Strategic Communications
Valter Pinto, Managing Director
PH: (212) 896-1254
[email protected] 

Media Contact:

KCSA Strategic Communications
Michaela Fawcett, Senior Account Director
PH: (978) 995-4683
[email protected]

TULSA, Okla., Sept. 15, 2026 (GLOBE NEWSWIRE) — ONEOK, Inc. (NYSE: OKE) today announced the pricing terms of ONEOK, L.L.C.’s (“OpCo”) previously announced cash tender offers (the “Tender Offers”) to purchase up to an aggregate principal amount that will not result in an aggregate purchase price that exceeds $2 billion (subject to increase or decrease by OpCo, the “Aggregate Maximum Tender Amount”) of OpCo’s debt securities listed in the table below (the “Notes” and, each series, a “series of Notes”), subject to the order of priority as set forth in the table below under “Acceptance Priority Level,” upon the terms and subject to the conditions set forth in the Offer to Purchase, dated August 30, 2026 (the “Offer to Purchase”), in order to accept all of the Notes that were validly tendered and not validly withdrawn at or prior to the Early Tender Deadline (as defined below). As a result of the reorganization transactions described in the Offer to Purchase, the Notes are fully and unconditionally guaranteed by ONEOK, as Parent Guarantor.

The “Early Tender Consideration” for each $1,000 principal amount of Notes validly tendered and accepted for purchase pursuant to the Tender Offers was determined by reference to the applicable Fixed Spread specified for that series over the Reference Yield based on the bid side price of the applicable Reference Security, in each case set forth in the table below, and is payable to the registered holders (“Holders”) of the Notes who validly tendered and did not validly withdraw their Notes at or before the Early Tender Deadline and whose Notes are accepted for purchase by OpCo. The applicable Reference Yields listed in the table were determined at 9:00 a.m., New York City time, today, September 15, 2026, by the Dealer Manager (as defined below). The “Tender Offer Consideration” for each $1,000 principal amount of Notes validly tendered after the Early Tender Deadline but at or before 5:00 p.m., New York City time, on September 29, 2026, unless extended or earlier terminated by us (such time, the “Expiration Time”), and accepted for purchase is the applicable Early Tender Consideration minus $50, which is the Early Tender Premium. In addition, each Holder will receive accrued and unpaid on such $1,000 principal amount of Notes validly tendered and accepted for purchase from the last interest payment date to, but not including, the Early Settlement Date.

The following table sets forth certain information regarding the Notes and the Tender Offers:

All conditions of the Tender Offers were deemed satisfied by OpCo, or timely waived by OpCo. Accordingly, OpCo expects to accept for purchase, and pay for, $2 billion aggregate principal amount of Notes validly tendered (and not validly withdrawn) on the Early Settlement Date (as defined in the Offer to Purchase), which is expected to occur on September 17, 2026. All payments for Notes purchased in connection with the Early Tender Deadline will also include accrued and unpaid interest from and including the last interest payment date applicable to the relevant series of Notes up to, but not including, the Early Settlement Date for such Notes accepted for purchase.

Although the Tender Offers are scheduled to expire at 5:00 p.m., New York City time, on September 29, 2026, because the aggregate principal amount of all Notes validly tendered and not validly withdrawn by the Early Tender Deadline is equal to the Aggregate Maximum Tender Amount, OpCo does not expect to accept for purchase any tenders of Notes after the Early Tender Deadline. Any Notes tendered after the Early Tender Deadline will be promptly credited to the account of the Holders of such Notes maintained at the Depository Trust Company and otherwise returned in accordance with the Offer to Purchase.

Full details of the terms and conditions of the Tender Offers are described in the Offer to Purchase, which was sent by OpCo to Holders of the Notes. Holders of the Notes are encouraged to read the Offer to Purchase as it contains important information regarding the Tender Offers.

OpCo has retained Barclays Capital Inc. to serve as Dealer Manager for the Tender Offers. D.F. King & Co., Inc. has been retained to serve as the Information and Tender Agent for the Tender Offers. Questions regarding the Tender Offers may be directed to Barclays Capital Inc. at 745 Seventh Avenue, 5th Floor, New York, New York 10019, (800) 438-3242 (toll free) or (212) 528-7581 (collect). Requests for the Offer to Purchase may be directed to D.F. King & Co., Inc. at 28 Liberty Street, 53rd Floor, New York, New York 10005, (646) 690-9645 (for banks and brokers) or (800) 967-7510 (for all others), or by email ([email protected]). OpCo is making the Tender Offers only by, and pursuant to, the terms of the Offer to Purchase. None of OpCo, the Dealer Manager, or the Information and Tender Agent make any recommendation as to whether Holders should tender or refrain from tendering their Notes. Holders must consult their own investment and tax advisors and make their own decisions as to whether to tender their Notes and, if so, the principal amount of the Notes to tender. The Tender Offers are not being made to holders of the Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In any jurisdiction in which the securities laws or blue sky laws require the Tender Offers to be made by a licensed broker or dealer, the Tender Offers will be deemed to be made on behalf of OpCo by the Dealer Manager, or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy the securities described above, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

——————————————————————————————————————        
At ONEOK (NYSE: OKE), we deliver energy products and services vital to an advancing world. We operate as a holding company, and our operations are conducted through OpCo and its subsidiaries. We are a leading midstream operator that provides gathering, processing, fractionation, transportation, storage and marine export services. Through our approximately 60,000-mile pipeline network, we transport the natural gas, natural gas liquids (NGLs), refined products and crude oil that help meet domestic and international energy demand, contribute to energy security and provide safe, reliable and responsible energy solutions needed today and into the future. As one of the largest integrated energy infrastructure companies in North America, ONEOK is delivering energy that makes a difference in the lives of people in the U.S. and around the world.

ONEOK is an S&P 500 company headquartered in Tulsa, Oklahoma.

This communication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included in this communication that address activities, events or developments that ONEOK expects, believes or anticipates will or may occur in the future are forward-looking statements.

These forward-looking statements include, but are not limited to, statements regarding timing and consummation of the purchase of the Notes, risks and uncertainties related to the satisfaction of the conditions related to the purchase of the Notes. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this communication. These include the risk that changes in ONEOK’s capital structure could have adverse effects on the market value of its securities; the risk that ONEOK may be unable to reduce expenses or access financing or liquidity; risks related to the impact of any economic downturn and any substantial decline in commodity prices; risks related to ONEOK’s ability to effectively manage our expanded operations following closing of recent acquisitions and other important factors that could cause actual results to differ materially from those projected.

Forward-looking statements include the items identified in the preceding paragraph, the information concerning possible or assumed future results of our operations and other statements contained or incorporated in this news release identified by words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “intend,” “may,” “might,” “outlook,” “plan,” “potential,” “project,” “scheduled,” “should,” “will,” “would” and other words and terms of similar meaning.

One should not place undue reliance on forward-looking statements. Known and unknown risks, uncertainties and other factors may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by forward-looking statements. Those factors may affect our operations, markets, products, services and prices. These and other risks are described in greater detail in Item 1A, Risk Factors, in our most recent Annual Report on Form 10-K and in the other filings that we make with the Securities and Exchange Commission (SEC), which are available on the SEC’s website at www.sec.gov. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Any such forward-looking statement speaks only as of the date on which such statement is made, and, other than as required under securities laws, we undertake no obligation to update publicly any forward-looking statement whether as a result of new information, subsequent events or change in circumstances, expectations or otherwise.

Contacts:

Investor Relations:

Megan Patterson
918-561-5325
[email protected] 

Media Relations:

Alicia Keenom
918-861-3749
[email protected] 

NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas on behalf of all persons or entities who purchased or otherwise acquired AST SpaceMobile, Inc. (“AST” or the “Company”) (NASDAQ: ASTS) securities between March 4, 2025 and July 15, 2026, inclusive (the “Class Period”).

The Complaint alleges that Defendants failed to disclose to investors that: (i) AST’s increasing capital requirements were likely to increase the Company’s debt load and share dilution with greater frequency and at greater scale than Defendants had signaled to investors; (ii) accordingly, Defendants had overstated the sufficiency of AST’s capital and liquidity position to achieve its strategic and business goals; (iii) Defendants likewise overstated the durability of AST’s competitive position in the satellite D2C market; (iv) even following the EchoStar Transaction, Defendants continued overstating AST’s competitive position in the satellite D2C market; (v) AST was experiencing slow user adoption in the U.S. and Japan; (vi) the foregoing was likely to have a significant negative impact on the Company’s business and financial prospects; and (vii) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

Investors who purchased or otherwise acquired shares of AST should contact the Firm prior to the November 13, 2026 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].

Please visit our website at http://www.gme-law.com for more information about the firm.

Company to own each project vehicle and all project-level economics across a coordinated program of ten 9.9 MW sites

WEST PALM BEACH, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) — FingerMotion, Inc. (Nasdaq: FNGR) (“FingerMotion” or the “Company”) today provided an update on its Alberta power and compute development program. The Company is advancing ten 9.9 megawatt behind-the-meter generation and data hall sites grouped into four campuses in Brooks, Coronation, Fox Creek and Vulcan, Alberta, representing 99 megawatts of gross generation capacity in development.

Each site is being developed in a dedicated Alberta project company. FingerMotion is the sole shareholder of each project company, which holds title to the land, permits and site agreements. Development, construction and site operations are performed by BlueFlare Group Holdings Inc., which takes title to none of the project assets.

What FingerMotion Is Seeking to Achieve

FingerMotion’s overall goal is to own behind-the-meter power generation and data hall capacity in Alberta at scale, and to contract that capacity to artificial intelligence and high-performance computing customers under long-term agreements. The Company is working toward the following objectives:

• Completing permitting on all ten 9.9 megawatt sites—representing 99 megawatts of gross generation capacity and approximately 72 megawatts of aggregate continuous critical IT capacity—by the end of the first quarter of 2027.
• Contracting that capacity under long-term take-or-pay agreements before committing construction capital to any individual site.
• Energizing sites beginning in late fourth quarter 2026, with data halls reaching turnover approximately 18 months from award of the applicable permit.
• Expanding each campus by adding further 9.9 megawatt sites in the same area as customer demand requires, rather than by increasing the permitted capacity of an existing site.
• Entering permitting on a further fifteen 9.9 megawatt sites beginning in the first quarter of 2027.

Management Commentary

“Power is the constraint on artificial intelligence infrastructure right now, and it is going to stay the constraint,” said Jolie Kahn, Chief Executive Officer of FingerMotion. “Our objective is straightforward: to own permitted, behind-the-meter generation and the data halls that sit on it, and to contract that capacity on long-term take-or-pay terms before we spend construction dollars on any single site. We are communicating what we are building, what we own, and the order in which we intend to do it. The project companies sit under FingerMotion, and the value created in them sits with FingerMotion.”

Scope of the Business

FingerMotion’s Alberta program provides land, permits, the project vehicle, gas supply, generation, power to the rack, cooling, hall and white space, physical security and site operations. Customers provide their own graphics processing units, servers, network equipment, transport and platform software. The Company does not own, lease, finance or resell GPUs and is not a cloud provider; it does not sell compute, GPU-as-a-service or any managed artificial intelligence platform.

About FingerMotion, Inc.

FingerMotion, Inc. (Nasdaq: FNGR) is a technology company historically focused on mobile payment, recharge, and data-analytics markets in the People’s Republic of China. Under current management, the Company is extending its strategy into enterprise AI and high-performance computing infrastructure in North America, including through its equity interest in Lyken AI Computing Inc., while evaluating its China operations.

Investor Contact

Investor Relations
FingerMotion, Inc.
Email: [email protected]

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding the Company’s Alberta development program; the number, size, location and timing of sites; anticipated permitting, construction and energization timelines; the anticipated structure of customer contracts; the expected effect of the Company’s procurement position; the ratification, terms and performance of the Strategic Development & Acquisition Agreement; the Company’s stated objectives; the commercial terms on which the Company intends to contract capacity, including term, escalation, availability and credit support; the contracting structures the Company intends to offer; and expectations regarding additional sites and campus expansion.

These statements are based on management’s current expectations and are subject to significant risks and uncertainties. No customer offtake agreement has been executed, and there can be no assurance that any customer contract will be entered into on the terms described or at all. Additional risks include the Company’s ability to obtain permits on the anticipated timeline, to complete land acquisitions, to ratify or complete definitive documentation of the Strategic Development & Acquisition Agreement, to obtain project financing on acceptable terms or at all, to procure equipment as scheduled, to complete construction on budget, to secure natural gas supply, and to contract capacity on the commercial terms described or on any terms; changes in Alberta regulatory requirements; changes in commodity prices; competition; and the other risk factors described in the Company’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.

Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

###

A securities class action alleges Lincoln Educational Services reported 9% enrollment growth in the second quarter of 2026, but student starts increased by only about 1%, revealing an admissions shortfall that was allegedly undisclosed until after LINC shares had peaked at $55.68.

NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) — SueWallSt notifies purchasers of Lincoln Educational Services Corporation (NASDAQ: LINC) securities that a class action lawsuit has been filed on behalf of shareholders who acquired securities between May 11, 2026 and August 9, 2026. Find out if you might qualify for recovery. You may also contact Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.

LINC shares fell $10.22, or 24.93%, to close at $30.77 on August 10, 2026 on unusually heavy trading volume, down from a Class Period high of $55.68 reached on July 7, 2026. Motions for lead plaintiff must be filed with the Court by November 10, 2026.

How a Career School Converts Enrollment Into Revenue

A signed enrollment generates nothing. Tuition revenue at a career-oriented postsecondary operator begins only when an enrolled student actually starts classes, making the conversion of enrolled students into student starts a critical driver of the Company’s revenue and financial performance. For the first quarter of 2026, the Company reported student starts up 19.5% to 5,500, average student population up 18.2%, and revenue up 22.5% to $144.0 million.

The Alleged Enrollment-to-Start Conversion Breakdown

On August 10, 2026, the Company reported that second quarter enrollment grew approximately 9% while student starts increased only about 1%, “as fewer enrolled students than expected attended the first day of class.” On the earnings call, the Company’s chief financial officer stated that “[d]espite . . . high single-digit enrollment in line with our expectations heading into the quarter, a lower percentage have converted to starts,” and that the lower start volume contributed to a higher cost per start. Management separately attributed part of the softness to the government requiring students to begin repaying loans in May, with some of those borrowers defaulting nine to ten months later. The action contends that this conversion deterioration was developing while investors were told the Company’s operations were performing as represented.

Alleged Conversion Impact by the Numbers

• Second quarter student starts grew approximately 1% against enrollment growth of approximately 9%, as pleaded in the action
• First quarter start growth of 19.5% preceded the second quarter slowdown to roughly 1%
• Full-year student start growth guidance of 10% to 14% was reiterated on August 10, 2026 despite the quarterly shortfall
• Lower start volume drove a higher cost per start, according to the Company’s own second quarter commentary
• Adjusted EBITDA declined to $12.7 million in the second quarter compared from $15.5 million in the first quarter
• Plaintiffs allege the admissions process was not effectively converting enrolled students into attendees during the Class Period

“The complaint raises serious questions about whether investors received accurate information about the admissions pipeline when enrollment growth of roughly 9% translated into start growth of only about 1%,” said Joseph E. Levi, Esq. “Shareholders are entitled to a full accounting of what was known about conversion trends and when.”

Submit your information now or call (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the LINC Lawsuit

Q: What specific misstatements does the LINC lawsuit allege? A: The complaint alleges Lincoln Educational Services Corporation made materially false or misleading statements regarding its admissions process and its ability to convert enrolled students into actual student starts during the Class Period. When the Company disclosed that second quarter student starts grew only about 1% despite enrollment growth of approximately 9%, the stock price declined sharply.

Q: How much did LINC stock drop? A: Shares fell approximately 24.93%, a decline of $10.22 per share, after the Company disclosed that fewer enrolled students than expected attended the first day of class and that it observed changes in the student decision-making process affecting conversion from enrollment to start. Investors who purchased shares during the Class Period at artificially inflated prices and suffered losses may be eligible to seek compensation.

Q: What court was the LINC class action filed in? A: The case was filed in the United States District Court for the District of New Jersey, governed by the Private Securities Litigation Reform Act of 1995.

Q: What documents do I need to submit my information? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What happens after I contact Levi & Korsinsky? A: An attorney will review your trading history at no cost and provide an initial assessment of your potential eligibility.

Q: What if I already sold my LINC shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.

Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. If there is a settlement or recovery, eligible class members generally submit a claim form to seek their portion.

Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in the securities class action, they are generally handled on a contingency basis, with any attorneys’ fees and expenses subject to court approval.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (888) SueWallSt
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

Important information: a securities class action alleges FuelCell omitted known manufacturing shortfalls under the Fit Energy purchase agreement.

NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) — SueWallSt notifies investors in FuelCell Energy, Inc. (NASDAQ: FCEL) that a securities class action naming Chief Executive Officer Jason B. Few and Chief Financial Officer Michael S. Bishop as individual defendants has been filed on behalf of shareholders who purchased securities between June 24, 2026 and September 1, 2026. Find out if you may be eligible to recover losses. You may also contact Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.

FCEL closed at $14.40 on September 2, 2026, a one-day decline of $2.68 per share, or 15.69%, after the Company reported a $17.0 million charge tied to Phase 0 of the Fit Energy capital equipment purchase agreement and a fiscal third quarter net loss of $45.3 million. Shares had closed as high as $36.01 on June 30, 2026. The window to apply for lead plaintiff closes on November 10, 2026.

The Named Individual Defendants

Few served as President and Chief Executive Officer at all relevant times, and Bishop served as Chief Financial Officer at all relevant times. The complaint charges that both officers possessed the power and authority to control the contents of the Company’s SEC reports, press releases, and presentations to analysts and institutional investors, received those materials before or shortly after issuance, and had the opportunity to prevent or correct them.

As alleged, the officers “possessed the power and authority to control the contents of the Company’s reports to the SEC, press releases and presentations to … the market.” The lawsuit asserts that positive statements about FuelCell’s business, operations, and prospects lacked a reasonable basis because the Company’s capacity was allegedly inadequate to generate the production rate required under the Fit Energy agreement, and because higher product costs and manufacturing overhead were allegedly a known trend affecting profitability.

Alleged Control Person Liability

• Alleged control over the content of SEC filings, press releases, and communications with the investing public during the Class Period
• Alleged access to internal budgets, plans, projections, and production reporting
• Alleged ability and opportunity to prevent or correct statements claimed to be materially misleading
• Section 20(a) claims seeking to hold each officer accountable for the Company’s alleged primary violations of Section 10(b) and Rule 10b-5

“Corporate officers have a duty to ensure their companies’ public statements are accurate and complete, and the complaint alleges that did not happen here when a $17.0 million charge tied to the Fit Energy agreement surfaced only at quarter end. Shareholders are entitled to have those allegations tested.” — Joseph E. Levi, Esq.

Submit your information to learn more or call (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the FCEL Lawsuit

Q: What court was the FCEL class action filed in? A: The case was filed in the United States District Court for the Southern District of New York, governed by the Private Securities Litigation Reform Act of 1995.

Q: Who are the defendants named in the FCEL lawsuit? A: The complaint names FuelCell Energy, Inc. and individual defendants including senior executives, CEO Jason B. Few and CFO Michael S. Bishop.

Q: What is the FCEL class action lawsuit about? A: A securities class action has been filed against FuelCell Energy, Inc. (NASDAQ: FCEL) alleging materially false and misleading statements between June 24, 2026 and September 1, 2026. Shares fell approximately 15.69% after the Company disclosed that product costs and manufacturing overhead exceeded the contractual pricing established under the Fit Energy CEPA, resulting in a $17.0 million charge. Investors who purchased shares during the Class Period and suffered losses may be eligible to seek compensation.

Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.

Q: What do FCEL investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible as an absent class member.

Q: What if I already sold my FCEL shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.

Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. If there is a settlement or recovery, eligible class members generally submit a claim form to seek their portion.

Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in the securities class action, they are generally handled on a contingency basis, with any attorneys’ fees and expenses subject to court approval.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (888) SueWallSt
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.